TRAM Snapshot of App at Pub for Oppostn

YONSA SUPPORT

Sun Pharma Global FZE

TRAM Snapshot of App at Pub for Oppostn

Trademark Snap Shot Publication Stylesheet
(Table presents the data on Publication Approval)

OVERVIEW

SERIAL NUMBER 88032046 FILING DATE 07/10/2018
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE SERVICE MARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY SIRIGNANO, EMMA MARIE
L.O. ASSIGNED 113

PUB INFORMATION

RUN DATE 01/07/2021
PUB DATE 06/11/2019
STATUS 819-SU - REGISTRATION REVIEW COMPLETE
STATUS DATE 01/06/2021
LITERAL MARK ELEMENT YONSA SUPPORT

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) YES 1 (a) NO
1 (b) YES 1 (b) NO 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT YONSA SUPPORT
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 20-OWNER AT PUBLICATION
NAME Sun Pharma Global FZE
ADDRESS Executive Suite Y-43
P.O. Box 122304, SAIF Zone
Sharjah, 
ENTITY 99-Free Zone Establishment
CITIZENSHIP United Arab Emirates

GOODS AND SERVICES

INTERNATIONAL CLASS 035
          DESCRIPTION TEXT Business administration of pharmacy reimbursement program and co-pay support programs; retail pharmacy services; mail order pharmacy services; online retail pharmacy services; pharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies
INTERNATIONAL CLASS 036
          DESCRIPTION TEXT Patient benefits programs in connection with pharmaceutical services, namely, providing financial assistance for disadvantaged persons for pharmaceuticals; Patient support and assistance in connection with pharmaceutical services, namely, providing information about eligibility for financial assistance provided through patient benefits programs; Insurance services in the form of insurance verification services and prior authorization services, namely, verifying Medicaid, Medicare, and commercial insurance eligibility status in the field of medical and pharmaceutical insurance and related insurance information for others; financial administration of pharmacy reimbursement program and co-pay support programs

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 035 FIRST USE DATE 08/27/2018 FIRST USE IN COMMERCE DATE 08/27/2018 CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 036 FIRST USE DATE 08/27/2018 FIRST USE IN COMMERCE DATE 08/27/2018 CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO
DISCLAIMER W/PREDETER TXT "SUPPORT"

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
01/07/2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED 035
01/06/2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED 034
12/17/2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 033
12/16/2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 032
12/16/2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 031
06/18/2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED 030
06/18/2020 GNRT O NON-FINAL ACTION E-MAILED 029
06/18/2020 CNRT W SU - NON-FINAL ACTION - WRITTEN 028
05/22/2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 027
05/22/2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 026
05/21/2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 025
12/31/2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED 024
12/31/2019 GNRT O NON-FINAL ACTION E-MAILED 023
12/31/2019 CNRT W SU - NON-FINAL ACTION - WRITTEN 022
12/11/2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE 021
12/04/2019 IUAF S USE AMENDMENT FILED 020
12/11/2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL 019
12/04/2019 EISU I TEAS STATEMENT OF USE RECEIVED 018
08/06/2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT 017
06/11/2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED 016
06/11/2019 PUBO A PUBLISHED FOR OPPOSITION 015
05/22/2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED 014
05/03/2019 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED 013
05/03/2019 ALIE A ASSIGNED TO LIE 012
04/19/2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER 011
04/18/2019 DOCK D ASSIGNED TO EXAMINER 010
04/04/2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 009
04/03/2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 008
04/03/2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 007
10/04/2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED 006
10/04/2018 GNRT F NON-FINAL ACTION E-MAILED 005
10/04/2018 CNRT R NON-FINAL ACTION WRITTEN 004
09/28/2018 DOCK D ASSIGNED TO EXAMINER 003
07/14/2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
07/13/2018 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Craig Kuchii
CORRESPONDENCE ADDRESS Craig Kuchii
Sun Pharmaceutical Industries, Inc.
2 INDEPENDENCE WAY
INTELLECTUAL PROPERTY DEPT.
PRINCETON, NJ 08540
DOMESTIC REPRESENTATIVE NONE

PRIOR OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME Sun Pharma Global FZE
ADDRESS Executive Suite Y-43
P.O. Box 122304, SAIF Zone
Sharjah, 
ENTITY 99-Free Zone Establishment
CITIZENSHIP United Arab Emirates

TRAM Snapshot of App at Pub for Oppostn [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed